Comparative study of the antibacterial penetrating effects of wound dressings

Journal of Plastic Surgery and Hand Surgery

Volumn 46, Issue 1, 2012, Pages 2-7

  Fujiwara, Toshihiro ^a   Nishimoto, Soh ^a   Ishise, Hisako ^a   Kawai, Kenichiro ^a   Fukuda, Kenji ^a   Kakibuchi, Masao ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Antibacterial penetration effect; Infected wound; LB agar media; Non pathogenic Escherichia coli; Wound dressings

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; BANDAGE; BIOAVAILABILITY; COMPARATIVE STUDY; CULTURE MEDIUM; DRUG EFFECT; ESCHERICHIA COLI; GRANULATION TISSUE; GROWTH, DEVELOPMENT AND AGING; HUMAN; IN VITRO STUDY; MICROBIOLOGY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; BANDAGES; BIOLOGICAL AVAILABILITY; CULTURE MEDIA, CONDITIONED; ESCHERICHIA COLI; GRANULATION TISSUE; HUMANS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; WOUND INFECTION;

EID: 84859121709     PISSN: 2000656X     EISSN: None     Source Type: Journal    
DOI: 10.3109/2000656X.2011.644939     Document Type: Article

References (19)

1. Miller CN, Newall N, Kapp SE, et al. A randomizedcontrolled trial comparing cadexomer iodine and nanocrystalline silver on the healing of leg ulcers. Wound Repair Regen 2010;18:359-67.
2. Weinstein DA, Kirsner RS. Refractory ulcers: the role of tumor necrosis factor-alpha. J Am Acad Dermatol 2010;63: 146-54.
3. de Araujo T, Valencia I, Federman DG, Kirsner RS. Managing the patient with venous ulcers. Ann Intern Med 2003;138:326-34. (Pubitemid 36205930)
4. Steed DL. Foundations of good ulcer care. Am J Surg 1998; 176:20-5.
5. Sibbald RG, Browne AC, Coutts P, Queen D. Screening evaluation of an ionized nanocrystalline silver dressing in chronic wound care. OstomyWoundManage 2001;47:38-43.
6. Siddiqui AR, Bernstein JM. Chronic wound infection: facts and controversies. Clin Dermatol 2010;28:519-26.
7. Hammond AA, Miller KG, Kruczek CJ, et al. An in vitro biofilm model to examine the effect of antibiotic ointments on biofilms produced by burn wound bacterial isolates. Burns 2011;37:312-21.
8. Atiyeh BS, Dibo SA, Hayek SN. Wound cleansing, topical antiseptics and wound healing. Int Wound J 2009;6:420-30.
9. Lipsky BA, Hoey C. Topical antibacterial therapy for treating chronic wounds. Clin Infect Dis 2009;49:1541-9.
10. Ammons CB. Anti-biofilm strategies and the need for innovations in wound care. Recent Pat Antiinfect Drug Discov 2010;5:10-7.
11. Browne AC, Vearncombe M, Sibbald RG. High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft. Ostomy Wound Manage 2001;47:44-9.
12. Leaper DJ. Risk factors for and epidemiology of surgical site infections. Surg Infect (Larchmt) 2010;11:283-7.
13. Van Den Plas D, De Smet K, Lens D, Sollie P. Differential cell death programmes induced by silver dressings in vitro. Eur J Dermatol 2008;18:416-21. (Pubitemid 352031852)
14. Paddle-Ledinek JE, Nasa Z, Cleland HJ. Effect of different wound dressings on cell viability and proliferation. Plast Reconstr Surg 2006;117:110-8.
15. Cooper RA. Iodine revisited. Int Wound J 2007;4:124-37.
16. Cooper ML, Laxer JA, Hansbrough JF. The cytotoxic effects of commonly used topical antibacterial agents on human fibroblasts and keratinocytes. J Trauma 1991;31:775-82.
17. Wiegand C, Heinze T, Hipler UC. Comparative in vitro study on cytotoxicity, antibacterial activity, and binding capacity for pathophysiological factors in chronic wounds of alginate and silver-containing alginate. Wound Repair Regen 2009;17:511-21.
18. Khan MN, Naqvi AH. Antiseptics, iodine, povidone iodine and traumatic wound cleansing. J Tissue Viability 2006;16: 6-10.
19. Fuller FW. The side effects of silver sulfadiazine. J Burn Care Res 2009;30:464-70.